Story at-a-glance
- A preprint paper showing ivermectin’s effectiveness against COVID-19 in Peru convinced a group of doctors that widespread ivermectin distribution could end the pandemic in October 2020
- Because the paper wasn’t yet peer-reviewed, it was brushed off; ivermectin for COVID-19 was vilified, as were those who dared to prescribe it
- Now, the study has been peer-reviewed and published in Cureus, vindicating ivermectin as a treatment for COVID-19
- Not only did ivermectin work against COVID-19, it was remarkably effective, resulting in a 74% reduction in excess deaths in the 10 Peru states where it was used most intensively
- There was a 14-fold reduction in nationwide excess deaths when ivermectin was readily available and then a 13-fold increase in excess deaths in the two months after ivermectin use was restricted
As the COVID pandemic wore on, with potential treatments supposedly unknown, New York pulmonologist Dr. Pierre Kory and others tried to get the word out about ivermectin. A widely used antiparasitic drug that’s listed on the World Health Organization’s essential medicines list1 and approved by the U.S. Food and Drug Administration, ivermectin is widely available, inexpensive and has a long history of safe usage.
Continue reading “Ivermectin Worked: New Peer-Reviewed Study Proves It”